Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response

• Main Author: Bryce M. Warner
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Pathogens
• Subjects: animal model; hemorrhagic fever; hemorrhagic fever viruses; Ebola virus; Lassa virus; pathogen dose
• Online Access: https://www.mdpi.com/2076-0817/10/3/275

Viral hemorrhagic fever viruses come from a wide range of virus families and are a significant cause of morbidity and mortality worldwide each year. Animal models of infection with a number of these viruses have contributed to our knowledge of their pathogenesis and have been crucial for the development of therapeutics and vaccines that have been approved for human use. Most of these models use artificially high doses of virus, ensuring lethality in pre-clinical drug development studies. However, this can have a significant effect on the immune response generated. Here I discuss how the dose of antigen or pathogen is a critical determinant of immune responses and suggest that the current study of viruses in animal models should take this into account when developing and studying animal models of disease. This can have implications for determination of immune correlates of protection against disease as well as informing relevant vaccination and therapeutic strategies.